COMBINATION OF THROMBOLYTICALLY ACTIVE PROTEINS AND ANTICOAGULANTS Russian patent published in 2001 - IPC

Abstract RU 2166326 C2

FIELD: medicine. SUBSTANCE: thrombolytically active proteins are combined with anticoagulants when anticoagulant is not heparin. Anticoagulant is administrated as an intravenous injection of impact acute dose while thrombolytically active protein can be administrated by an intravenous impact acute dose or by an intravenous infusion. Invention ensures to avoid repeated occlusion that results to decrease of the course of acute myocardial infarction and decrease of lethality by 30%. EFFECT: enhanced curative effectiveness of combination. 10 cl, 3 tbl, 5 dwg,1 ex

Similar patents RU2166326C2

Title Year Author Number
PLATELET-SPECIFIC CHIMERIC IMMUNOGLOBULIN AND METHODS OF ITS USING 1994
  • Barri S.Koller
  • Dehvid N.Najt
RU2158135C2
BIFUNCTIONAL VARIANT OF UROKINASE, PLASMID CONTAINING SYNTHETIC STRUCTURAL GENE ENCODING BIFUNCTIONAL UROKINASE, PLASMID (VARIANTS), METHOD OF PLASMID PREPARING, METHOD OF BIFUNCTIONAL VARIANT OF UROKINASE PREPARING, THROMBOLYTIC AGENT 1994
  • Gerd J. Shteffens
  • Stefan Vnendt
  • Jokhannes Shnajder
  • Regina Khajntsel'-Viland
  • Derek Dzhon Sonders
RU2143490C1
PHARMACEUTICAL PREPARATION CONTAINING PLASMINOGEN ACTIVATORS 1995
  • Ul'Rikh Konert
  • Shtefan Fisher
  • Khans-Jorg Markl
  • Khajnrikh Voog
RU2155067C2
METHOD FOR SIMULATING THROMBUS FORMATION IN MICE FOR ASSESSING EFFECT OF ANTICOAGULANT PREPARATIONS 2014
  • Revishchin Aleksandr Nikolaevich
  • Zav'Jalova Elena Gennadievna
  • Samojlenkova Nadezhda
  • Golovin Andrej Viktorovich
  • Pavlova Galina Valerievna
  • Kopylov Aleksej Mikhajlovich
RU2570162C1
USE OF ACTIVATED BLOOD COAGULATION FACTOR VII FOR TREATMENT OF EXTENSIVE BLOODINGS CAUSED BY THROMBOLYTIC THERAPY 2001
  • Skamira Kord
  • Shtassen Zhan Mari
  • Khojzel' Gerkhard
  • Vinen Vol'Fgang
RU2286796C2
PHARMACEUTICAL COMBINED PREPARATIONS CONTAINING ERYTHROPOIETIN AND IRON PREPARATIONS 1996
  • Lemann Paul'
RU2173168C2
DNA FRAGMENT CODING POLYPEPTIDE K2P WITH PLASMINOGEN ACTIVATOR PROPERTIES, POLYPEPTIDE K2P WITH PLASMINOGEN ACTIVATOR PROPERTIES, RECOMBINANT PLASMIDA DNA PA27 1990
  • Anne Shtern[De]
  • Ul'Rikh Konert[De]
  • Rajner Rudol'F[De]
  • Shtefan Fisher[De]
  • Ul'Rikh Martin[De]
RU2107094C1
USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS 2021
  • Zhang Guimin
  • Yao Jingchun
  • Sun Chenghong
  • Li Bin
  • Pan Sina
RU2806093C1
POLYPEPTIDE WITH BIOLOGICAL ACTIVITY OF INHIBITOR OF COLLAGEN-INDUCED ADHESION OF PLATELETS, ITS PREPARING AND USING 2000
  • Shtrittmatter Vol'Fgang
  • Gjussov Detlef
  • Khofmann Uve
  • Khemberger Jurgen
  • Fotef Zizi
  • Shojble Bernkhard
RU2292351C2
ANTIFIBRIN ANTIBODY FOR USE AS ANTITHROMBOTIC AGENT 1995
  • Gargan Pol I.
RU2152801C2

RU 2 166 326 C2

Authors

Ul'Rikh Martin

Shtefan Fisher

Dates

2001-05-10Published

1995-03-22Filed